Managing rare diseases: examples of national approaches in Europe, North America and East Asia
Rare Disease and Orphan Drugs Journal · 2022 · 1 (2) · 10
DOI: 10.20517/rdodj.2022.02 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rare Disease and Orphan Drugs Journal, 2022. Verfasst von Lucas Cortial und 6 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref).
Abstract (Originalsprache)
Around 4% of the global population suffers from a rare disease. Apart from the medical aspect, economic, organisational, and political approaches remain key aspects when it concerns the evolution of the world of rare diseases. We review here the principal specific national initiatives and organisations in Europe, North America and East Asia. Thereafter, we propose the outlines of a possible optimal approach, inspired by the successes of the individual national organisations. This work should be taken into account in the definition of large scale multi-national rare diseases programs, such as the European Joint Programme on Rare Diseases.
Zitieren
APA
Cortial, L., Nguyen, C., Julkowska, D., Cocqueel-Tiran, F., Moliner, A. M., Blin, O., & Trentesaux, V. (2022). Managing rare diseases: examples of national approaches in Europe, North America and East Asia. Rare Disease and Orphan Drugs Journal, 1(2), 10. https://doi.org/10.20517/rdodj.2022.02
Vancouver
Cortial L, Nguyen C, Julkowska D, Cocqueel-Tiran F, Moliner AM, Blin O, et al. Managing rare diseases: examples of national approaches in Europe, North America and East Asia. Rare Disease and Orphan Drugs Journal. 2022;1(2):10. doi:10.20517/rdodj.2022.02
BibTeX
@article{Cortial2022,
author = {Cortial, Lucas and Nguyen, Catherine and Julkowska, Daria and Cocqueel-Tiran, Florence and Moliner, Antoni Montserrat and Blin, Olivier and Trentesaux, Valérie},
title = {Managing rare diseases: examples of national approaches in Europe, North America and East Asia},
journal = {Rare Disease and Orphan Drugs Journal},
year = {2022},
volume = {1},
number = {2},
pages = {10},
doi = {10.20517/rdodj.2022.02}
}
EUVIMED